TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinib

Tumor protein p53 (TP53) is a tumor suppressor gene and TP53 mutations are associated with poor prognosis in non-small cell lung cancer. However, the in-depth classification of TP53 and its relationship with treatment response and prognosis in epidermal growth factor receptor (EGFR)-mutant tumors tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Ruofei, Bai, Hua, Li, Tangai, Gao, Bingyu, Han, Jiefei, Chang, Geyun, Zhang, Pei, Fei, Kailun, He, Xiran, Wang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254117/
https://www.ncbi.nlm.nih.gov/pubmed/34192651
http://dx.doi.org/10.1016/j.tranon.2021.101163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254117/
https://www.ncbi.nlm.nih.gov/pubmed/34192651
http://dx.doi.org/10.1016/j.tranon.2021.101163

Ejemplares similares